This page lists the SEC filings reported by 5AM Ventures VI, L.P..
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13D/A | 2024-04-15 | 5AM Ventures VI, L.P. | Enliven Therapeutics, Inc. | 2,366,178 | 5.1% | EDGAR |
| SC 13D/A | 2024-02-16 | 5AM Ventures VI, L.P. | Enliven Therapeutics, Inc. | 3,200,634 | 7.8% | EDGAR |
| SC 13D/A | 2024-02-14 | 5AM Ventures VI, L.P. | Vor Biopharma Inc. | 4,595,089 | 6.8% | EDGAR |
| SC 13D/A | 2024-02-02 | 5AM Ventures VI, L.P. | Enliven Therapeutics, Inc. | 3,888,992 | 9.4% | EDGAR |
| SC 13D/A | 2023-08-28 | 5AM Ventures VI, L.P. | Enliven Therapeutics, Inc. | 4,470,968 | 10.9% | EDGAR |
| SC 13D | 2023-03-06 | 5AM Ventures VI, L.P. | Enliven Therapeutics, Inc. | 4,838,092 | 11.8% | EDGAR |
| SC 13D/A | 2023-02-28 | 5AM Ventures VI, L.P. | CinCor Pharma, Inc. | 0 | 0.0% | EDGAR |
| SC 13D | 2023-01-18 | 5AM Ventures VI, L.P. | CinCor Pharma, Inc. | 3,953,990 | 9.0% | EDGAR |
| SC 13G | 2022-01-21 | 5AM Ventures VI, L.P. | CinCor Pharma, Inc. | 3,841,323 | 10.5% | EDGAR |
| SC 13D | 2021-02-19 | 5AM Ventures VI, L.P. | Vor Biopharma Inc. | 4,833,959 | 13.0% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.